- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diffuse Large Cell Lymphoma
Total 6963 results
-
Han weidongRecruitingRelapsed and Refractory B-cell Non-Hodgkin's Lymphoma | Decitabine-primed Tandem CD19/CD20 CAR T CellsChina
-
New York Medical CollegeUniversity of Alabama at BirminghamRecruitingPeripheral T Cell Lymphoma | NK-Cell Lymphoma | NK-Cell LeukemiaUnited States
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingLymphoblastic Lymphoma, ChildhoodSpain, Austria, Denmark, Finland, Germany, Belgium, Switzerland, China, Czechia, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden
-
Mingzhi ZhangUnknownT-lymphoblastic LymphomaChina
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)
-
Georg Aue, M.D.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Tongji Hospital; Qilu Hospital... and other collaboratorsActive, not recruiting
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
CStone PharmaceuticalsNot yet recruitingExtranodal NK/T-cell Lymphoma
-
Memorial Sloan Kettering Cancer CenterRecruitingCutaneous T-cell LymphomaUnited States
-
Sun Yat-sen UniversityRecruiting
-
EQRx International, Inc.No longer availableExtranodal NK/T-cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Childhood T Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Ruijin HospitalNot yet recruitingNK-T-Cell Lymphoma, ExtranodalChina
-
European Organisation for Research and Treatment...RecruitingStage IB-IIB Cutaneous T-Cell LymphomaSpain, United Kingdom, Denmark, Italy, France, Germany, Greece
-
Sichuan UniversityUnknown
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedLymphoma | Leukemia | Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | AML | Acute Myelogenous Leukemia | Hematologic Malignancy | Myeloma | Non-hodgkin's Lymphoma | CLL | ALLUnited States
-
Sun Yat-sen UniversityNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
ImmuneOncia Therapeutics Inc.Active, not recruitingA Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal TypeExtranodal NK/T-cell Lymphoma, Nasal Type | Extranodal NK/T-cell LymphomaKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedExtranodal NK/T Cell Lymphoma, Nasal TypeChina
-
Ruijin HospitalActive, not recruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Sun Yat-sen UniversityEli Lilly and CompanyUnknownExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
National Cancer Institute (NCI)CompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Fudan UniversityUnknownExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Burkitt Lymphoma | Childhood Lymphoblastic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Cutaneous | T-CellUnited States
-
Falo, Louis, MDActive, not recruitingCutaneous T Cell LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSActive, not recruitingRelapsed T-Cell Lymphoma | Refractory T-Cell LymphomaItaly
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Mundipharma (China) Pharmaceutical Co. LtdCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed T-Cell LymphomaChina
-
University of Michigan Rogel Cancer CenterWithdrawnCutaneous T Cell LymphomaUnited States
-
Stefan Schieke MDWithdrawnCutaneous T-cell Lymphoma (CTCL)United States
-
Florida Academic Dermatology CentersCelgene CorporationUnknownCutaneous T Cell LymphomaUnited States
-
Fudan UniversityUnknown
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, Australia, Switzerland, Puerto Rico
-
Grupo de Estudos Multicentricos em Onco-HematologiaTakedaUnknownT-cell Lymphoma | NK-Cell Lymphoma | T-cell Lymphoma Adults
-
Fate TherapeuticsRecruitingLymphoma, B-Cell | Chronic Lymphocytic Leukemia | Precursor B-Cell Acute Lymphoblastic LeukemiaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
Royal Marsden NHS Foundation TrustUnknownMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United Kingdom
-
AstraZenecaActive, not recruitingPhase I: Relapsed or Refractory B-cell Malignancies | Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma | Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic LeukemiaChina
-
Centre Henri BecquerelUnknownLymphoblastic LymphomaBelgium, France
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Stage I Mantle Cell Lymphoma | Stage II Contiguous Mantle Cell Lymphoma | Stage II Non-Contiguous Mantle Cell LymphomaUnited States
-
SymBio PharmaceuticalsCompletedLow-grade B Cell Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not IndicatedJapan
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Anhui Medical University; Henan Cancer Hospital and other collaboratorsRecruitingInduction Chemotherapy | Acute T-Lymphocytic Leukemia | T-cell Lymphoblastic Lymphoma Leukemia | T-cell/Myeloid Mixed Phenotype Acute LeukemiaChina
-
TakedaCompletedPeripheral T Cell Lymphoma | Pediatric Hodgkin LymphomaJapan
-
Ou Bai, MD/PHDSecond Hospital of Jilin University; China-Japan Union Hospital, Jilin UniversityRecruitingAngioimmunoblastic T-cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedChina